RECONDRIA Trademark

Trademark Overview


On Wednesday, December 24, 2008, a trademark application was filed for RECONDRIA with the United States Patent and Trademark Office. The USPTO has given the RECONDRIA trademark a serial number of 77639761. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, September 10, 2009. This trademark is owned by Pfizer Inc.. The RECONDRIA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
recondria

General Information


Serial Number77639761
Word MarkRECONDRIA
Filing DateWednesday, December 24, 2008
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, September 10, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, September 10, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, September 10, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, September 10, 2009ABANDONMENT - AFTER PUBLICATION
Wednesday, September 9, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, July 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Saturday, March 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 14, 2009ASSIGNED TO LIE
Friday, March 13, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 13, 2009ASSIGNED TO EXAMINER
Monday, December 29, 2008NEW APPLICATION ENTERED IN TRAM